A new trading day began on Tuesday, with Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) stock price down -6.00% from the previous day of trading, before settling in for the closing price of $3.5. MRVI’s price has ranged from $1.66 to $6.21 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -64.27%. Meanwhile, its annual earnings per share averaged -213.35%. With a float of $105.64 million, this company’s outstanding shares have now reached $144.72 million.
Let’s determine the extent of company efficiency that accounts for 570 employees.
Maravai LifeSciences Holdings Inc (MRVI) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Maravai LifeSciences Holdings Inc is 27.16%, while institutional ownership is 78.15%. The most recent insider transaction that took place on Dec 23 ’25, was worth 13,138. Before that another transaction happened on Dec 19 ’25, when Company’s Former Director proposed sale 53,951 for $3.48, making the entire transaction worth $187,526.
Maravai LifeSciences Holdings Inc (MRVI) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.06 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -213.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -16.72% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Here are Maravai LifeSciences Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Looking closely at Maravai LifeSciences Holdings Inc (NASDAQ: MRVI), its last 5-days average volume was 1.26 million, which is a drop from its year-to-date volume of 2.06 million. As of the previous 9 days, the stock’s Stochastic %D was 10.19%.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 66.33%, which indicates a significant increase from 2.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.41, while its 200-day Moving Average is $2.65. However, in the short run, Maravai LifeSciences Holdings Inc’s stock first resistance to watch stands at $3.43. Second resistance stands at $3.57. The third major resistance level sits at $3.65. If the price goes on to break the first support level at $3.21, it is likely to go to the next support level at $3.13. Now, if the price goes above the second support level, the third support stands at $2.99.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
With a market capitalization of 841.27 million, the company has a total of 255,707K Shares Outstanding. Currently, annual sales are 259,190 K while annual income is -144,850 K. The company’s previous quarter sales were 41,630 K while its latest quarter income was -25,560 K.
